|  Help  |  About  |  Contact Us

Publication : Gigaxonin mutation analysis in patients with NIFID.

First Author  Dequen F Year  2011
Journal  Neurobiol Aging Volume  32
Issue  8 Pages  1528-9
PubMed ID  19782434 Mgi Jnum  J:305245
Mgi Id  MGI:6708698 Doi  10.1016/j.neurobiolaging.2009.08.018
Citation  Dequen F, et al. (2011) Gigaxonin mutation analysis in patients with NIFID. Neurobiol Aging 32(8):1528-9
abstractText  Neuronal intermediate filament inclusion disease (NIFID) is a frontotemporal lobar degeneration (FTLD) characterized by frontotemporal dementia (FTD), pyramidal and extrapyramidal signs. The disease is histologically characterized by the presence of abnormal neuronal cytoplasmic inclusions (NCIs) which contain alpha-internexin and other neuronal intermediate filament (IF) proteins. Gigaxonin (GAN) is a cytoskeletal regulating protein and the genetic cause of giant axonal neuropathy. Since the immunoreactive profile of NCIs in NIFID is similar to that observed in brain sections from Gan(Deltaex1/Deltaex1) mice, we speculated that GAN could be a candidate gene causing NIFID. Therefore, we performed a mutation analysis of GAN in NIFID patients. Although the NCIs of NIFID and Gan(Deltaex1/Deltaex1) mice were immunohistochemically similar, no GAN variant was identified in DNA obtained from well-characterized cases of NIFID.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression